Medical Science Liaison
SK Life Science
Medical Science Liaison
SK Life Science
Develops CNS and cancer therapies
The Medical Science Liaison (MSL) will be responsible for providing non-promotional scientific, educational, and research support for the company and their CNS portfolio in the Rocky Mountain region, with the key states of Colorado, Arizona and Utah. The MSL position is a field based member of the Medical /Clinical Affairs team. The MSL should be highly trained in a health care field and well-versed in clinical and for basic science to be able to deliver cutting edge data and technical/practical education to Health Care Professionals (HCP).
The MSL will be responsible for developing and maintaining relationships with key CNS experts and building a well-informed advocacy base for the company’s CNS franchise, including compounds in the development program. The MSL will act as a conduit for providing accurate and updated clinical, scientific and medical information to Key Opinion Leaders (KOL’s) in Epilepsy, CNS/Neurology, Health Care Professionals, treatments decision makers and other members of the scientific, provider and payer community (private insurance, payers, medical groups, government agencies, and health systems with drug formularies), in compliance with all relevant company policies.
Responsibilities:
Educational Requirements:
Experience:
Compensation & Benefits
The anticipated salary range for this position is $160,000 to $215,000. Actual compensation may vary based on factors including experience, qualifications, skills, and business needs.
In addition to base salary, SK Life Science offers a competitive benefits package, including a 401(k) plan with company match and medical, dental, and vision coverage. Benefits are subject to eligibility requirements and may be modified at the Company's discretion.
Develops CNS and cancer therapies
SK Life Science is a U.S. subsidiary focused on developing medicines for central nervous system (CNS) disorders and cancer. Its work centers on researching and bringing pharmaceutical treatments to market that address neurological diseases and oncology, leveraging the broader SK Group’s resources and expertise. The company’s products work by targeting disease mechanisms in CNS conditions or cancer, delivered through conventional pharmaceutical formulations developed through its science-driven pipeline (as part of SK Biopharmaceuticals). What sets SK Life Science apart from competitors is its backing by SK Group and SK Biopharmaceuticals, enabling strong research, development, and global scale, as well as a stated commitment to real patient impact in CNS and oncology. The company aims to transform lives by delivering meaningful treatments that improve outcomes for patients with CNS disorders and cancer.
Explore more opportunities at SK Life Science